Vaibhav Chauhan
Vaibhav has joined The George Institute for Global Health India as Director of Finance and Administration, bringing extensive expertise in accounting, planning, controllership, taxation, compliance, and operations.
Prior to joining The George Institute, Vaibhav has led the Finance and Operations for Protiviti India, where he played a key role in driving their financial growth and transformation. His diverse experience spans leadership roles at bioMérieux, SRF Limited, and HCL Technologies.
Vaibhav is a Chartered Accountant, a Company Secretary and a US Certified Public Accountant by profession and holds a Commerce degree from Delhi University and postgraduation from IMT. And driven by the passion for innovation, he is continuously expanding his expertise in AI & ML and applying it to enhance financial excellence.
His expertise in navigating complex financial and operational landscapes has been recognized with many prestigious accolades such as India's Top 100 CFOs, Business World’s Top40 CFOs Under40 & Exceptional Finance Manager, and Financial Express Finance Visionary Leader.
Australian High Commissioner announces DAP Grant to The George Institute for Global Health, India to implement Mental Health initiatives in Telangana
Trial into radio waves treatment for chronic lower back pain secures $3.6M grant
Understanding long term outcomes of sepsis
$5.5M NHMRC grant will power trial of precision medicine in sepsis care
Dr Gautam Satheesh selected for the prestigious Emerging Leaders and the Emerging Voices for Global Health programs
Dr Marino Festa
Marino Festa is an Honorary Fellow in the Critical Care and Trauma Division of The George Institute. He is a senior staff specialist and co-lead for Kids Critical Care Research at The Children’s Hospital at Westmead (CHW) in Sydney.
He is a fellow of the College of Intensive Care Medicine and has completed a Doctor of Medicine (Research), Imperial College, London 2011. He represents CHW on the paediatric study group of the ANZICS Clinical Trial Group and is principal investigator for the SAFE EPIC global point prevalence study.
He has active research interests in the areas of paediatric fluid resuscitation, microvascular adaptation to shock, and human factors research in critically ill and simulated patients.
Professor Mark Huffman
Prof. Mark Huffman, a Professorial Fellow at The George Institute for Global Health and Adjunct Professor at UNSW, is a globally recognized preventive cardiologist with over a decade of experience in cardiovascular dissemination and implementation research. He is a Professor of Medicine (Cardiology) and Co-Director of the Global Health Center at Washington University in St. Louis and Adjunct Professor of Preventive Medicine at Northwestern University.
He is a Fellow of the American Heart Association and the American College of Cardiology and was recognised as an Emerging Leader in Health and Medicine through the National Academy of Medicine. He is a standing member of the NIH Science of Implementation for Health and Health Care study section.
He co-created the World Heart Federation’s flagship Emerging Leaders program, which has trained >200 early-to-mid-career professionals from >50 countries in implementation research. Prof. Huffman has taught graduate-level courses, co-directed the NIH/Fogarty-funded global health fellows’ research training program, and mentored undergraduate, graduate, postgraduate, and early-stage investigator trainees in implementation research.
Marna van Zyl
Marna van Zyl is Legal Director at The George Institute.
Dr Meena Thuraisingham
Dr Meena Thuraisingham is Founder and Principal at BoardQ and TalentInvest. She is also a Non-Executive Director of the Shared Value Project and Linden Art Gallery.
Meena has previously held executive roles at ANZ, including Global Head of Leadership and Talent and Head of Human Resources, Corporate & Institutional Bank. She has also held senior consultant roles with two global consulting firms.
Meena joined the Board in January 2018 and is a Member of the Risk Committee.
Associate Professor Meg Jardine
A/Professor Meg Jardine is a Honorary Professorial Fellow at The George Institute for Global Health.
Her research interests centre on preventing the progression and complications of kidney disease and diabetes. She has a particular interest in using innovative trial designs to better generate evidence to improve outcomes. Dr Jardine leads the RESOLVE and BEAT-Calci trials and was the Global Scientific Lead of the CREDENCE study and CI of the ACTIVE and FINESSE trials. Her advocacy for kidney disease is pursued through memberships of the Board of the Kidney Health Initiative (KHI), the Executive Committee of the international KDIGO guidelines group and the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) core committee.
Meg Jardine is a practising physician and nephrologist at Concord Repatriation General Hospital